戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 th most strains, including highly pathogenic avian influenza.
2 rus antibodies from a patient vaccinated for avian influenza.
3      Human infections with highly pathogenic avian influenza A (H5N1) virus are frequently fatal but
4 fluenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus induce expression of tumo
5                     Two epidemic waves of an avian influenza A (H7N9) virus have so far affected Chin
6  such as the 2009 pandemic influenza A H1N1, avian influenza A H5N1 virus subtype, or the avian influ
7                                              Avian influenza A H5N1 viruses have caused many, typical
8                                              Avian influenza A H7 viruses have caused multiple outbre
9                  In the years prior to 2013, avian influenza A H7 viruses were a cause of significant
10                    On 30 March 2013, a novel avian influenza A H7N9 virus causing severe human respir
11                                          The avian influenza A H7N9 virus has caused infections in hu
12 his study, we isolated and characterized the avian influenza A H7N9 virus in Guangdong, China, from A
13 avian influenza A H5N1 virus subtype, or the avian influenza A H7N9 virus subtype.
14        The potential role of wild mammals in avian influenza A virus (IAV) transmission cycles has re
15 r the course of two waves of infection, H7N9 avian influenza A virus has caused 436 human infections
16  these results suggest that PB1-F2 from H7N9 avian influenza A virus may be a major contributory fact
17                                              Avian influenza A virus polymerases typically do not fun
18 he localization of PB2 of human from that of avian influenza A virus strains.
19                       During 2013, three new avian influenza A virus subtypes, A(H7N9), A(H6N1), and
20 ted for cases of human infection by emerging avian influenza A virus subtypes, including H7N9 and H10
21                   Human infections caused by avian influenza A virus type subtype H7N9 have been asso
22 blish a new lineage in the human population, avian influenza A viruses (AIV) must overcome the intrac
23                                              Avian influenza A viruses (IAV) of the H9N2 subtype have
24             Building on the observation that avian influenza A viruses (IAVs) have a tropism for the
25                Ducks are the natural host of avian influenza A viruses and display few or no disease
26 ly bind alpha2,6-linked sialic acids whereas avian influenza A viruses bind alpha2,3-linked sialic ac
27                                              Avian influenza A viruses have gained increasing attenti
28 necessary for introduction and adaptation of avian influenza A viruses to mammalian hosts is importan
29 the introduction and subsequent spread of an avian influenza A(H10N7) virus among harbor seals of nor
30  that it was most closely related to various avian influenza A(H10N7) viruses.
31 igenic features related to low pathogenicity avian influenza A(H3N2) viruses and were distinct from A
32 equences of representative highly pathogenic avian influenza A(H5) viruses from Vietnam were generate
33 after the emergence of human infections with avian influenza A(H5N1) and has evolved over time, with
34                            Highly pathogenic avian influenza A(H5N1) causes severe infections in huma
35 he immunogenicity and protective efficacy of avian influenza A(H5N1) vaccine.
36 estigated 2 human cases of highly pathogenic avian influenza A(H5N1) virus infection, detected throug
37 tation and reassortment of highly pathogenic avian influenza A(H5N1) viruses at the animal-human inte
38 cal evidence that the direction of spread of avian influenza A(H7N7) is correlated with the direction
39 rly 2013, >440 human cases of infection with avian influenza A(H7N9) have been reported including 122
40                              The fatality of avian influenza A(H7N9) infection in humans was over 30%
41                          Human infections by avian influenza A(H7N9) virus entail substantial morbidi
42 c influenza A(H1N1) virus (A[H1N1]pdm09) and avian influenza A(H7N9) virus hemagglutinins (HAs) despi
43                The first identified cases of avian influenza A(H7N9) virus infection in humans occurr
44                         Human infection with avian influenza A(H7N9) virus is associated mainly with
45 hina in April 2013 of human illnesses due to avian influenza A(H7N9) virus provided reason for US pub
46                    Human infections with the avian influenza A(H7N9) virus were first reported in Chi
47     Almost 700 cases of human infection with avian influenza A/H7N9 have been reported since 2013.
48                        Human infections with avian influenza A/H7N9 have resulted in high morbidity a
49 ed cases is the key to control the spread of avian influenza (AI) H5N1.
50 ghly pathogenic (HP) and low-pathogenic (LP) avian influenza (AI) H5N2 and H7N1 were investigated dur
51 resolution (cell size: 500m x 500m) maps for Avian Influenza (AI) suitability in each of the four Nor
52                            Seropositivity to avian influenza (AI) via low-level antibody titers has b
53 ated the replication of wt and ca viruses of avian influenza (AI) virus subtypes H5N1, H6N1, H7N3, an
54 ins, such as the triple reassortment of H7N9 avian influenza and the formation of circulating HIV-1 r
55  randomly assigned to receive 3.75 microg of avian influenza Anhui vaccine with or without MF59 adjuv
56 oultry, human exposure to and infection with avian influenza becomes more common.
57  (CEFs) for studies on avian viruses such as avian influenza but no comprehensive study has as yet be
58 ation) with vaccine directed toward an older avian influenza H5 strain might lead to secondary antibo
59 d approach was to select a low-pathogenicity avian influenza H5 virus that elicited antibodies that c
60 used the ferret model to address this for an avian influenza H5N1 vaccine.
61           The emergence of highly pathogenic avian influenza H5N1 viruses has raised concerns about t
62              Clade 2.2.2.1 highly pathogenic avian influenza H5N1 viruses were isolated from the case
63  pandemic H1N1 (pH1N1) and highly pathogenic avian influenza H5N1 viruses.
64  H1N1 pandemic (pH1N1) and highly pathogenic avian influenza H5N1 viruses.
65 atory pathogens including influenza viruses (avian influenza H5N1, H7N9, and H10N8; variant influenza
66 dence data of outbreaks of highly pathogenic avian influenza (H5N1) in Egypt, available through the o
67 fluenza (pdmH1N1) virus or highly pathogenic avian influenza (H5N1) virus elicits robust, cross-react
68            Since May 2014, highly pathogenic avian influenza H5N6 virus has been reported to cause si
69            Recently, novel highly pathogenic avian influenza H5Nx viruses (clade 2.3.4.4) caused outb
70         The emergence of a highly pathogenic avian influenza H7N3 virus in poultry throughout the sta
71             An outbreak of highly pathogenic avian influenza H7N7 virus in Italy during 2013 resulted
72                        Human infections with avian influenza H7N9 or H10N8 viruses have been reported
73  up to 90% mortality in humans, whereas H5N1 avian influenza has a 60% fatality rate.
74 de 2.3.4.4 CVVs.IMPORTANCE Highly pathogenic avian influenza (HPAI) A(H5) viruses have circulated con
75  outbreaks of newly found, highly pathogenic avian influenza (HPAI) A(H5N8) viruses have been reporte
76                   In 2015, highly pathogenic avian influenza (HPAI) H5 viruses have caused outbreaks
77                        The highly pathogenic avian influenza (HPAI) H5N1 viruses continue to circulat
78 uses in mammals.IMPORTANCE Highly pathogenic avian influenza (HPAI) H5N1 viruses continue to evolve i
79  pandemic H1N1 (pH1N1) and highly pathogenic avian influenza (HPAI) H5N1 viruses.
80             Emergence of a highly pathogenic avian influenza (HPAI) H5N8 virus in Asia and its spread
81                    A novel highly pathogenic avian influenza (HPAI) H5N8 virus, first detected in Jan
82 m infected during the 2013 highly pathogenic avian influenza (HPAI) H7N7 epidemic in Italy to unravel
83      With the emergence of highly pathogenic avian influenza (HPAI) H7N9 and H5N1 strains, there is a
84                            Highly Pathogenic Avian Influenza (HPAI) has recently (2014-2015) re-emerg
85 evolutionary dynamics of a highly pathogenic avian influenza (HPAI) strain during a naturally occurri
86 fluenza virus A/H1N1/2009, highly pathogenic avian influenza (HPAI) virus A/H5N1, and oseltamivir-res
87                    An H7N8 highly pathogenic avian influenza (HPAI) virus and an H7N8 low-pathogenic
88                            Highly pathogenic avian influenza (HPAI) virus H5N1 has been enzootic in E
89                      H5N1 high-pathogenicity avian influenza (HPAI) virus has become endemic in Indon
90 tbreak of clade 2.3.4.4 H5 highly pathogenic avian influenza (HPAI) virus that occurred in the United
91 1 (A/Vietnam/1203/2004), a highly pathogenic avian influenza (HPAI) virus, between HN and L (PIV5-NP-
92  viruses, such as the H5N1 highly pathogenic avian influenza (HPAI) virus, pose not only pandemic thr
93  Eurasian clade 2.3.4.4 H5 highly pathogenic avian influenza (HPAI) virus.
94 nd mortality annually, and highly pathogenic avian influenza (HPAI) viruses along with other emerging
95 2016, the presence of H7N8 highly pathogenic avian influenza (HPAI) viruses and closely related H7N8
96 ental spread of H5 subtype highly pathogenic avian influenza (HPAI) viruses of the A/goose/Guangdong/
97   The spread of H5 subtype highly pathogenic avian influenza (HPAI) viruses of the Gs/GD lineage by m
98                            Highly pathogenic avian influenza (HPAI) viruses of the H5N1 subtype are e
99                            Highly pathogenic avian influenza (HPAI) viruses of the H5N1 subtype conti
100         Infections with H7 highly pathogenic avian influenza (HPAI) viruses remain a major public hea
101 the potential to mutate to highly pathogenic avian influenza (HPAI) viruses, but such viruses' origin
102 tect poultry against H5N1 high-pathogenicity avian influenza (HPAI).
103 as to reduce the risk of future epidemics of avian influenza in China.
104 on the seasonality of H5N1 Highly Pathogenic Avian Influenza in the domestic poultry population of Vi
105 e 2009 swine flu pandemic, highly pathogenic avian influenza infections, and the most recent early an
106 elded 10 (6.7%) additional highly pathogenic avian influenza isolates (H5N8 = 3 and H5N2 = 7).
107 reover, major western and eastern hemisphere avian influenza lineages inferred for each gene coalesce
108           In December 2016, a low-pathogenic avian influenza (LPAI) A(H7N2) virus was identified to b
109 s to use suitability maps for Low Pathogenic Avian Influenza (LPAI) to identify areas at high risk fo
110 rus or rg-generated PWT/06 low-pathogenicity avian influenza (LPAI) virus seed strains protected chic
111 enza (HPAI) virus and an H7N8 low-pathogenic avian influenza (LPAI) virus were recently isolated from
112              Introductions of low-pathogenic avian influenza (LPAI) viruses of subtypes H5 and H7 int
113 uses and closely related H7N8 low-pathogenic avian influenza (LPAI) viruses was confirmed in commerci
114 birds and their associated low-pathogenicity avian influenza (LPAI) viruses.
115  and then with sequences taken from the H7N7 avian influenza outbreak that occurred in the Netherland
116 th recent concern over the highly pathogenic avian influenza outbreaks around the world, government a
117  with seasonal variation in the incidence of avian influenza outbreaks in the North of the country, t
118      However, detailed mechanisms underlying avian influenza pathogenicity are still undetermined.
119  frequent PB2-PB1-PA-NP cosegregation during avian influenza reassortment.
120 e of HA proteins including those from recent avian influenza strains A(H5N1) and A(H7N9).
121 rapid method to screen for highly pathogenic avian influenza strains that may be indicators of future
122                        The highly pathogenic avian influenza subtype H5N1 (HPAI H5N1) is a worldwide
123 ovel influenza strains through reassortment, avian influenza subtypes such as H5N1, H7N7, H7N2, H7N3
124 y was initiated to conduct highly pathogenic avian influenza surveillance in wild birds in the Pacifi
125 should be taken into consideration in future avian influenza vaccine trials.
126  emerge in Indonesia following widespread H5 avian influenza vaccine usage, and efficacious inactivat
127 esponses to a single dose of more current H5 avian influenza vaccine.
128 ans, the immune correlates of protection for avian influenza vaccines cannot be determined from clini
129                        Previous priming with avian influenza vaccines results in more rapid and more
130 udies, chickens immunized with any of the H5 avian influenza vaccines were protected against A/chicke
131 erated and characterized a virus composed of avian influenza viral segments with high homology to the
132 Vs in fruit bats and serological evidence of avian influenza virus (AIV) H9 infection in frugivorous
133                                         H9N2 avian influenza virus (AIV) has an extended host range,
134 ainst H7 (52%), H5 (55%) and H9 (6%) subtype avian influenza virus (AIV) in egg yolk samples, and 45%
135                                              Avian influenza virus (AIV) subtype H5N1 attracts partic
136 RNA oligonucleotide sequences related to the avian influenza virus (AIV) type H5N1.
137 tion of oligonucleotide sequences related to avian influenza virus (AIV) type H5N1.
138 y nodes, we infer that the internal genes of avian influenza virus (AIV) underwent a global selective
139 l determination of DNA sequence derived from Avian Influenza Virus (AIV), type H5N1.
140 fy an interaction between specific CHIRs and avian influenza virus (AIV).
141  intranasal infection with highly pathogenic avian influenza virus (H5N1 [A/Viet Nam/1203/2004]) in f
142 experienced several recent highly pathogenic avian influenza virus (HPAIV) epizootics.
143 on of the H5 HA of an H5N1 highly pathogenic avian influenza virus (HPAIV), A/Vietnam/1203/04 (VN1203
144              Our data provide a glimpse into avian influenza virus adaptation in mammals, with broad
145 rase genes are known to play a major role in avian influenza virus adaptation to mammalian hosts.
146 ential for reassortment of H1N1 viruses with avian influenza virus and emphasize the need for continu
147 zed human sera against the tl/TX/079/07 H3N8 avian influenza virus and observed low but detectable an
148 thern Vietnam, we tested for antibodies to 5 avian influenza virus antigens, using a protein microarr
149                    A novel highly pathogenic avian influenza virus belonging to the H5 clade 2.3.4.4
150 etain fusion and attachment properties of an avian influenza virus but displayed robust growth and co
151  are that a highly pathogenic strain of H7N1 avian influenza virus can be adapted to become capable o
152         Infection of naive ferrets with H5N1 avian influenza virus causes a rapid and lethal systemic
153 suggest that the Eurasian H5N8 clade 2.3.4.4 avian influenza virus emerged in late 2013 in China, spr
154                      However, information on avian influenza virus evolution and transmission during
155 c analyses revealed the global prevalence of avian influenza virus genes whose proteins differ only a
156 t HA (short and long) from highly pathogenic avian influenza virus H5N1 and the anti-H5 HA monoclonal
157 ng contrast, immunization of humans with the avian influenza virus H5N1 induced broadly cross-reactiv
158                   Finally, highly pathogenic avian influenza virus H5N1 polymerase activity was teste
159                                              Avian influenza virus H5N1, a serious worldwide threat t
160                                              Avian influenza virus H9N2 is prevalent in waterfowl and
161 hile M2 has previously been shown to protect avian influenza virus HA proteins of the H5 and H7 subty
162 protein has previously been shown to protect avian influenza virus HA proteins that contain a polybas
163 nuated influenza vaccines (LAIVs) expressing avian influenza virus hemagglutinins (HAs) prime for str
164                            Highly pathogenic avian influenza virus infection is characterized by a ma
165 tance of H9N2 viruses as the source of novel avian influenza virus infections in humans requires cont
166 se of the pathogenicity and low incidence of avian influenza virus infections in humans, the immune c
167 ary endothelial cells in the pathogenesis of avian influenza virus infections is largely unknown.
168                                         H9N2 avian influenza virus is a major cause of poultry produc
169             These results imply that when an avian influenza virus jumps the species barrier from bir
170                                              Avian influenza virus polymerases function poorly in mam
171                                              Avian influenza virus reassortants resembling the 1918 h
172 the possible role of PAM in the mediation of avian influenza virus resistance, we compared the host e
173 nly 1918 PB2 impacts the pathogenicity of an avian influenza virus sharing high homology to the 1918
174 uenza virus strain, a highly pathogenic H5N1 avian influenza virus strain, and a recently emerging H7
175            Influenza A(H5N1) virus and other avian influenza virus strains represent major pandemic t
176                            Highly pathogenic avian influenza virus subtype H5N1 is endemic in Asia, w
177 pendent cellular cytotoxicity (ADCC) against avian influenza virus subtypes, including H7N9 and H5N1,
178 the acquisition of the NS segment of an H5N1 avian influenza virus that had previously been overlooke
179        The zoonotic outbreak of H7N9 subtype avian influenza virus that occurred in eastern China in
180 ution PB2-A588V may be a new strategy for an avian influenza virus to adapt mammalian hosts.
181  use in the event of transmission of an H3N8 avian influenza virus to humans.
182 for HA conformational change, may facilitate avian influenza virus transmission via respiratory dropl
183 ild birds were sampled and highly pathogenic avian influenza virus was detected in 1.3% (n = 63).
184 14, a Eurasian strain H5N8 highly pathogenic avian influenza virus was detected in poultry in Canada.
185    Here, we characterize a low-pathogenicity avian influenza virus, A/chicken/Israel/810/2001 (H9N2)
186  pandemic H1N1 virus, highly pathogenic H5N1 avian influenza virus, and the recently emerged H7N9 str
187                                      A novel avian influenza virus, influenza A(H7N9), emerged in Chi
188 nction (GOF) research with highly pathogenic avian influenza virus, severe acute respiratory syndrome
189  during human infection with pathogenic H7N7 avian influenza virus.
190  vaccine is urgently needed against the H7N9 avian influenza virus.
191 erity of both seasonal and highly pathogenic avian influenza virus.
192 ed by furin, a hallmark of highly pathogenic avian influenza virus.
193 esence of a PB2 gene segment derived from an avian influenza virus.
194 DCs in the pathogenesis of highly pathogenic avian influenza virus.
195 and ferrets higher than that in an authentic avian influenza virus.
196  well as therapeutic treatments of HPAI H7N7 avian influenza virus.
197  focus of surveillance activities monitoring avian influenza viruses (AIV) circulating in poultry.
198 d, quantitative, and label-free detection of avian influenza viruses (AIV) H5N1.
199  Novel reassortants of H7N9, H10N8, and H5N6 avian influenza viruses (AIVs) are currently circulating
200                          Several subtypes of avian influenza viruses (AIVs) are emerging as novel hum
201                          Our surveillance of avian influenza viruses (AIVs) at Delaware Bay, USA, rev
202    Outbreaks of highly pathogenic strains of avian influenza viruses (AIVs) cause considerable econom
203 TANCE The frequency of human infections with avian influenza viruses (AIVs) has increased in recent y
204                                              Avian influenza viruses (AIVs) have been pivotal to the
205     Phylogenetic analysis of these two novel avian influenza viruses (AIVs) suggested that their geno
206 he best way to predict and identify emerging avian influenza viruses (AIVs) that pose a potential thr
207 ) against several NAs of wild-type human and avian influenza viruses (H1N1, H3N2, H5N1, and H7N9), al
208                            Highly pathogenic avian influenza viruses (HPAIV) induce severe inflammati
209 protection in mice against clade 0, 1, and 2 avian influenza viruses and also protected against seaso
210 ccines (pLAIV) representing four subtypes of avian influenza viruses and found that pLAIVs replicate
211 response to the continuing evolution of H5N1 avian influenza viruses and human infections, new candid
212  early apoptosis of PAM limits the spread of avian influenza viruses and that PB1-F2 could play a con
213                        Human infections with avian influenza viruses are a serious public health conc
214                       Highly pathogenic H5N1 avian influenza viruses are associated with severe disea
215                       Highly pathogenic H5N1 avian influenza viruses are associated with severe disea
216 hosts for avian influenza viruses.IMPORTANCE Avian influenza viruses are capable of crossing the spec
217                          A(H5N1) and A(H9N2) avian influenza viruses are enzootic in Egyptian poultry
218                                         H9N2 avian influenza viruses are enzootic in poultry across A
219                                Although most avian influenza viruses are harmless for humans, some (s
220                                     Emerging avian influenza viruses are of global concern because th
221 etween antigenic drift and viral fitness for avian influenza viruses as well as the challenges of pre
222 uctive and virulent infection of humans with avian influenza viruses can occur.
223                              Pathogenic H7N9 avian influenza viruses continue to represent a public h
224                                         Most avian influenza viruses do not replicate efficiently in
225  these parameters among a panel of human and avian influenza viruses exhibiting diverse respiratory d
226 s utility for monitoring the evolution of H9 avian influenza viruses from China between 2005 and 2015
227           Our results indicate that the H7N8 avian influenza viruses from Indiana are able to replica
228 ough mutation to which functional components avian influenza viruses gain the ability to grow efficie
229                                              Avian influenza viruses generally replicate at higher te
230                      We showed that the H9N2 avian influenza viruses harboring 190V in the HA exhibit
231 of-function' experiments on high-consequence avian influenza viruses has highlighted the role of ferr
232 acid substitutions in highly pathogenic H5N1 avian influenza viruses have been shown to contribute to
233                       Highly pathogenic H5N1 avian influenza viruses have caused outbreaks among poul
234                             Notably, certain avian influenza viruses have evolved to escape this rest
235 nfections in humans, as well as detection of avian influenza viruses in birds in the United States.
236 s of numerous outbreaks of highly pathogenic avian influenza viruses in commercial poultry farms.
237 to the low activity of the RNA polymerase of avian influenza viruses in mammalian cells.
238      The restrictions to transmissibility of avian influenza viruses in mammals are multigenic, and o
239 e essential for the efficient replication of avian influenza viruses in mammals.
240 e and genetic diversity of H7N9, we surveyed avian influenza viruses in poultry in Jiangsu province w
241 gated serological profiles against human and avian influenza viruses in the general population using
242 estrict the emergence and perpetuation of HP avian influenza viruses in these natural reservoirs.
243     Full length viral PB1-F2 present only in avian influenza viruses is a virulence factor that targe
244           The number of humans infected with avian influenza viruses is increasing, raising concerns
245 cate that the number of humans infected with avian influenza viruses is much larger than the number o
246 sence of an aspartic acid in over 95% of all avian influenza viruses is not, resulting in a clear dis
247  Nonstructural protein 1 (NS1) proteins from avian influenza viruses like the 1918 pandemic NS1 are c
248                          Vaccines against H7 avian influenza viruses may be more effective than HI an
249                       Highly pathogenic H5N1 avian influenza viruses must acquire mutations to overco
250                            Highly pathogenic avian influenza viruses of the H5N1 subtype continue to
251                Since 1997, highly pathogenic avian influenza viruses of the H5N1 subtype have been tr
252                                              Avian influenza viruses of the H5N1 subtype pose a serio
253                                              Avian influenza viruses of the H7 hemagglutinin (HA) sub
254 on of human influenza virus strains, whereas avian influenza viruses overcome these restriction facto
255                            Highly pathogenic avian influenza viruses pose a continuing global threat.
256 ction for prepandemic vaccines.IMPORTANCE H7 avian influenza viruses present a serious risk to human
257                                              Avian influenza viruses rarely infect humans, but the re
258                                    Human and avian influenza viruses recognize different sialic acid-
259 easing, raising concerns of the emergence of avian influenza viruses resistant to neuraminidase (NA)
260                                              Avian influenza viruses that cause infection and are tra
261 ows H7N9 and H5N1 as the latest in a line of avian influenza viruses that cause serious disease in hu
262 d as a reservoir of internal genes for other avian influenza viruses that infect humans, and several
263                We analyzed the adaptation of avian influenza viruses to a mammalian host by passaging
264 t insight into the potential for emerging H7 avian influenza viruses to acquire the ability to cause
265                               The ability of avian influenza viruses to adapt to new host species is
266  been shown to play a role in the ability of avian influenza viruses to cross the species barrier, an
267 s use of the codon usage biases of human and avian influenza viruses to generate a human-derived infl
268 NAI resistance among specific NA subtypes of avian influenza viruses to help guide clinical managemen
269         Furthermore, regular transmission of avian influenza viruses to humans increases the risk of
270 between antigenic drift and the potential of avian influenza viruses to infect humans.
271 The pH of HA activation of highly pathogenic avian influenza viruses was greater than human and low-p
272                        In contrast, selected avian influenza viruses were able to escape IFITM3 restr
273  in ferrets, demonstrating that contemporary avian influenza viruses with 1918 virus-like proteins ma
274 humans, some (such as highly pathogenic H5N1 avian influenza viruses) are capable of infecting humans
275 was greater than human and low-pathogenicity avian influenza viruses, as reported by others.
276                                              Avian influenza viruses, including H5N1 and H7N9, have b
277                    We found that a subset of avian influenza viruses, including potentially pandemic
278 r zoonotic and pandemic emergence.IMPORTANCE Avian influenza viruses, such as H9N2, cause disease in
279  virus was similar to Eurasian avian lineage avian influenza viruses, the virus had been circulating
280 omparing human seasonal influenza strains to avian influenza viruses, we provide greater insight into
281 mportant role in the evolutionary biology of avian influenza viruses-a manifestation of the "storage
282 ring therapeutic protection against human or avian influenza viruses.
283 with activity against highly pathogenic H5N1 avian influenza viruses.
284 hanisms of the differential pathogenicity of avian influenza viruses.
285 ent barrier against zoonotic transmission of avian influenza viruses.
286 ection with both low- and high-pathogenicity avian influenza viruses.
287 ing of the species barrier compared to other avian influenza viruses.
288  so that it is similar to that observed from avian influenza viruses.
289 at human disease caused by highly pathogenic avian influenza viruses.
290 redict the pandemic potential of circulating avian influenza viruses.
291  the virus is a reassortant of H7N9 and H9N2 avian influenza viruses.
292  infections highlight the threat of emerging avian influenza viruses.
293 thought to potentiate antigenic diversity in avian influenza viruses.
294  clear distinction between human-adapted and avian influenza viruses.
295 ltry farms in northwest Iowa for exposure to avian influenza viruses.
296 s virus can also reassort with H5N1 and H9N2 avian influenza viruses.
297  the assessment of the pandemic potential of avian influenza viruses.
298 t commonly considered intermediate hosts for avian influenza viruses.IMPORTANCE Avian influenza virus
299 ters were estimated for high pathogenic H5N1 avian influenza, which agree with previous findings.
300   This compound binds to hemagglutinin H5 of avian influenza with a dissociation constant of K(D) = 4

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top